Skip to content
How It Works
Explore
Ask a Question Resources Pricing
Who It's For
Patients
Decode results, prep for appointments, weigh options.
Caregivers & advocates
Carry the research load for someone you love.
Providers & clinicians
Resources for patients in your practice.
Log In Sign Up
PubMed This is a summary of 28 peer-reviewed journal articles Updated
Endocrinology

When Is Genetic Testing Recommended for Hypoparathyroidism?

At a Glance

Genetic testing is most often considered when hypoparathyroidism has no clear acquired cause, especially if it began early, runs in the family, or occurs with hearing, kidney, heart, or immune problems. A genetic counselor can help choose and interpret the right test.

In this answer

5 sections

01

Before You Test: The Initial Evaluation

02

Red Flags: When to Consider Testing

03

Common Genetic Causes and Syndromes

04

The Role of Genetic Counseling

05

Understanding Your Results

For most people with hypoparathyroidism, the condition happens because of neck surgery or radiation [1]. However, if your condition has no clear acquired cause, genetic testing might be the next step. Genetic testing looks for specific DNA changes (variants) that affect how your parathyroid glands develop or function [2]. Medical guidelines suggest considering a genetic evaluation if you were diagnosed before age 40, have a family history of the condition, or have other syndromic features (additional health issues that often appear together) [3][4]. Age 40 is not a strict rule, but rather a prompt for a deeper discussion with your endocrinologist [3].

Before You Test: The Initial Evaluation

Having unexplained hypocalcemia (low calcium) does not automatically mean you need a genetic test. Before considering genetics, an endocrinologist will first confirm your diagnosis by checking that your blood calcium is consistently low while your parathyroid hormone (PTH) is inappropriately low or normal [5]. They will also rule out other potential causes, such as low magnesium, kidney disease, certain medications, or rare infiltrative diseases [6][7].

Red Flags: When to Consider Testing

Doctors typically consider genetic testing for nonsurgical hypoparathyroidism when certain “red flags” are present in your medical history:

  • Early Onset: The condition began at a young age, particularly in childhood or infancy [3][8].
  • Family History: You have blood relatives with hypoparathyroidism, low calcium, unexplained seizures, or kidney stones [4][2].
  • Unusual Urine-Calcium Patterns: High levels of calcium in your urine (hypercalciuria) can be a clue. However, this finding must be interpreted carefully because standard calcium and active vitamin D treatments also increase urine calcium [9]. It is most suspicious for a genetic cause if your urine calcium was unusually high before starting treatment, or if it remains disproportionately high compared to your blood calcium levels [10][4].
  • Syndromic Features: You have other symptoms that seem unrelated but form a recognizable genetic pattern. This can include hearing loss, kidney problems, congenital heart defects, or persistent infections [3][8].

Common Genetic Causes and Syndromes

If your doctor recommends testing, they are usually looking for a few specific DNA changes or missing chromosome segments:

  • Autosomal Dominant Hypocalcemia (ADH): Caused by variants in the CASR or GNA11 genes, this condition makes your body’s calcium sensors overly sensitive [11][12]. “Autosomal dominant” means that inheriting a single copy of the altered gene from one parent is enough to cause the condition, and it can affect multiple generations [13].
    • Treatment Note: In ADH, trying to push blood calcium levels up to a standard “normal” range with aggressive supplements can severely worsen urine calcium, increasing the risk of kidney stones and kidney damage (nephrocalcinosis) [14][15]. If you have ADH, your doctor may aim for a lower blood calcium target [16]. Never change your calcium or medication doses without your clinician’s guidance.
  • 22q11.2 Deletion Syndrome: Often called DiGeorge syndrome, this is usually caused by a missing piece of a chromosome that includes multiple genes, rather than a single-gene spelling mistake [17][18]. It can cause hypoparathyroidism alongside heart defects, immune system problems, and facial differences. Standard DNA sequencing might miss this; a specialized test like a chromosomal microarray or targeted deletion testing is often needed [19][20].
  • HDR Syndrome: Caused by changes in the GATA3 gene, this syndrome involves Hypoparathyroidism, Deafness (sensorineural, or nerve-related hearing loss), and Renal (kidney) abnormalities [21][13].
  • Autoimmune Polyglandular Syndrome Type 1 (APS-1): Caused by variants in the AIRE gene, this involves hypoparathyroidism, recurrent mucocutaneous candidiasis (persistent yeast infections of the mouth, skin, or nails), and adrenal gland insufficiency [22][23].
    • Safety Note: If you have chronic yeast infections and symptoms of adrenal insufficiency (like extreme fatigue, weight loss, or low blood pressure), seek prompt medical evaluation, as adrenal issues can be medically serious and require immediate care.
  • Isolated Familial Hypoparathyroidism: Some gene variants, such as those in GCM2 or PTH, cause parathyroid problems without affecting any other part of the body [24][25].

The Role of Genetic Counseling

Before taking a genetic test, it is highly recommended to speak with a genetics professional. A counselor will explain that the right test must be matched to your symptoms—some panels look for spelling mistakes in specific genes, while others look for missing chunks of chromosomes [26][19].

A counselor will also help you navigate practical issues:

  • Privacy and Cost: What testing means for your insurance coverage and genetic privacy laws.
  • Incidental Findings: The possibility of discovering genetic risks for completely unrelated health conditions.
  • Cascade Testing: If a pathogenic (disease-causing) variant is confirmed, counselors can help coordinate testing for your at-risk blood relatives, such as siblings or children [27][26].

Understanding Your Results

Genetic testing results are rarely a simple “yes” or “no.” They generally fall into three categories:

Result Type What It Means Next Steps
Pathogenic Variant A known disease-causing DNA change was found. Your doctor may adjust your treatment targets, monitor your kidneys, or recommend cascade testing for your family [26][14].
Negative No known variants were found. This does not prove your condition isn’t genetic. It may mean science hasn’t discovered your specific variant yet, or a different type of test is needed [4][28]. Your doctor will continue treating your symptoms. Genetics specialists may reanalyze your results in the future as science advances.
Variant of Uncertain Significance (VUS) A DNA change was found, but doctors don’t know if it causes disease or is just a harmless quirk [8]. A VUS should not be used to change your treatment or test your family [27]. It may be reclassified later as more research is done [18].

Common questions in this guide

Why is genetic testing considered for some people with hypoparathyroidism?
It is considered when no clear acquired cause, such as neck surgery or radiation, explains the condition. Early onset, relatives with similar problems, or features such as hearing loss, kidney problems, heart defects, or persistent infections can strengthen the reason to test.
Does being diagnosed before age 40 mean I need genetic testing?
No. Diagnosis before age 40 is a prompt for deeper evaluation, not an automatic requirement for testing. An endocrinologist should confirm persistent low calcium with inappropriately low or normal parathyroid hormone and rule out other causes first.
What kinds of genetic tests may be used for hypoparathyroidism?
Testing may include a gene panel that looks for changes in several genes, such as CASR, GNA11, GATA3, AIRE, GCM2, or PTH. If a chromosome deletion is suspected, such as 22q11.2 deletion syndrome, a chromosomal microarray or targeted deletion test may be needed because standard gene sequencing can miss it.
What genetic conditions can cause hypoparathyroidism?
Examples include autosomal dominant hypocalcemia, 22q11.2 deletion syndrome, HDR syndrome, autoimmune polyglandular syndrome type 1, and isolated familial hypoparathyroidism. These conditions may also involve hearing, kidney, heart, immune, or adrenal problems.
What does a negative or uncertain genetic test result mean?
A negative result means that no currently recognized disease-causing variant was found, but it does not prove that the condition is not genetic. A variant of uncertain significance has an unclear effect and should not be used by itself to change treatment or test relatives. Results may be reinterpreted as medical knowledge advances.
How could a genetic result change treatment for hypoparathyroidism?
Changes in CASR or GNA11 can make the body's calcium sensors overly sensitive and cause high urine calcium. Raising blood calcium aggressively in this situation can increase the risk of kidney stones and kidney damage, so a clinician may choose a lower calcium target and closer kidney monitoring. Do not change calcium or medication doses without medical guidance.
Should I speak with a genetic counselor before testing?
Yes, a genetic counselor can help match the test to your symptoms and explain possible costs, privacy issues, and unexpected findings. If a disease-causing variant is found, the counselor can also discuss whether testing may help at-risk relatives.

Related questions

How Does Magnesium Affect Hypoparathyroidism and Calcium? What Medications Interact With Calcium Supplements? Why Is Calcitriol Used Instead of Regular Vitamin D? Can Hypoparathyroidism Cause Symptoms With Normal Calcium? Is Postsurgical Hypoparathyroidism Temporary or Permanent?
Show more
What Should I Do After Missing a Calcium or Calcitriol Dose? What Causes Nonsurgical Hypoparathyroidism in Adults? What Diet Is Recommended for Hypoparathyroidism? Food Tips How Do Hypoparathyroidism, PHP, and ADH Differ in Tests? Which Calcium Supplement Is Best for Hypoparathyroidism? Can Normal PTH Mean Hypoparathyroidism With Low Calcium? When Is Low Calcium from Hypoparathyroidism an Emergency? What Do Calcium Test Results Mean in Hypoparathyroidism? How Is High Phosphate Treated in Hypoparathyroidism? Can Illness or Surgery Lower Calcium in Hypoparathyroidism? Can Hypoparathyroidism Cause QT Prolongation or Arrhythmias? How Is Severe Hypocalcemia From Hypoparathyroidism Treated? Is Autoimmune Hypoparathyroidism Linked to APS-1 Syndrome? What Should I Do With Calcium and Calcitriol During Vomiting?

Get notified when new evidence is published on Hypoparathyroidism.

We monitor PubMed for new peer-reviewed studies on this topic and email a short summary when something meaningful changes.

References

References (28)
  1. 1

    HypoparaNet: A Database of Chronic Hypoparathyroidism Based on Expert Medical-Surgical Centers in Italy.

    Marcucci G, Cianferotti L, Parri S, et al.

    Calcified tissue international 2018; (103(2)):151-163 doi:10.1007/s00223-018-0411-7.

    PMID: 29511787
  2. 2

    Best practice recommendations for the diagnosis and management of hypoparathyroidism.

    Khan AA, Ali DS, Bilezikian JP, et al.

    Metabolism: clinical and experimental 2025; (171()):156335 doi:10.1016/j.metabol.2025.156335.

    PMID: 40581321
  3. 3

    Evaluation and Management of Hypoparathyroidism Summary Statement and Guidelines from the Second International Workshop.

    Khan AA, Bilezikian JP, Brandi ML, et al.

    Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research 2022; (37(12)):2568-2585 doi:10.1002/jbmr.4691.

    PMID: 36054621
  4. 4

    Genetic screening in a large Chinese cohort of adult-onset non-surgical hypoparathyroidism.

    Yang J, Jiang Y, Zhang B, et al.

    Endocrine 2025; (90(2)):926-940 doi:10.1007/s12020-025-04420-7.

    PMID: 40986257
  5. 5

    Diverse genetic aetiologies and clinical outcomes of paediatric hypoparathyroidism.

    Kim JH, Shin YL, Yang S, et al.

    Clinical endocrinology 2015; (83(6)):790-6 doi:10.1111/cen.12944.

    PMID: 26384470
  6. 6

    Causes and pathophysiology of hypoparathyroidism.

    Cianferotti L, Marcucci G, Brandi ML

    Best practice & research. Clinical endocrinology & metabolism 2018; (32(6)):909-925 doi:10.1016/j.beem.2018.07.001.

    PMID: 30665552
  7. 7

    Classification of Hypoparathyroid Disorders.

    Cianferotti L

    Frontiers of hormone research 2019; (51()):127-138 doi:10.1159/000491043.

    PMID: 30641517
  8. 8

    Genetic Screening in a Large Chinese Cohort of Childhood Onset Hypoparathyroidism by Next-Generation Sequencing Combined with TBX1-MLPA.

    Wang Y, Nie M, Wang O, et al.

    Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research 2019; (34(12)):2254-2263 doi:10.1002/jbmr.3854.

    PMID: 31433868
  9. 9

    Differential parathyroid and kidney Ca2+-sensing receptor activation in autosomal dominant hypocalcemia 1.

    van Megen WH, Tan RSG, Alexander RT, Dimke H

    EBioMedicine 2022; (78()):103947 doi:10.1016/j.ebiom.2022.103947.

    PMID: 35313217
  10. 10

    Autosomal Dominant Hypocalcemia With Atypical Urine Findings Accompanied by Novel CaSR Gene Mutation and VitD Deficiency.

    Tsuji T, Hiroyuki A, Uraki S, et al.

    Journal of the Endocrine Society 2021; (5(3)):bvaa190 doi:10.1210/jendso/bvaa190.

    PMID: 33506158
  11. 11

    Heterozygous Mutations in TBX1 as a Cause of Isolated Hypoparathyroidism.

    Li D, Gordon CT, Oufadem M, et al.

    The Journal of clinical endocrinology and metabolism 2018; (103(11)):4023-4032 doi:10.1210/jc.2018-01260.

    PMID: 30137364
  12. 12

    Autosomal Dominant Hypocalcemia (Hypoparathyroidism) Types 1 and 2.

    Roszko KL, Bi RD, Mannstadt M

    Frontiers in physiology 2016; (7()):458 doi:10.3389/fphys.2016.00458.

    PMID: 27803672
  13. 13

    The Syndrome of Familial Hypoparathyroidism, Sensorineural Deafness and Renal Dysplasia.

    Meena RL, Maloo SK, Samar N, et al.

    The Journal of the Association of Physicians of India 2015; (63(6)):73-5.

    PMID: 26710407
  14. 14

    Autosomal Dominant Hypocalcemia Type 1: A Systematic Review.

    Roszko KL, Stapleton Smith LM, Sridhar AV, et al.

    Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research 2022; (37(10)):1926-1935 doi:10.1002/jbmr.4659.

    PMID: 35879818
  15. 15

    Management of autosomal dominant hypocalcemia type 1: Literature review and clinical practice recommendations.

    De Coster T, David K, Breckpot J, Decallonne B

    Journal of endocrinological investigation 2025; (48(4)):831-844 doi:10.1007/s40618-024-02496-y.

    PMID: 39607645
  16. 16

    A novel gain-of-function mutation (W818R) of calcium-sensing receptor in a family with autosomal dominant hypocalcemia type 1.

    Fu M, Luo Y, Xu K, et al.

    Frontiers in endocrinology 2026; (17()):1806677 doi:10.3389/fendo.2026.1806677.

    PMID: 42181181
  17. 17

    An Endocrinological Perspective on 22q11.2 Deletion Syndrome: A Single-center Experience

    Denkboy Öngen Y, Özemri Sağ Ş, Temel ŞG, Eren E

    Journal of clinical research in pediatric endocrinology 2023; (15(3)):285-292 doi:10.4274/jcrpe.galenos.2023.2022-11-3.

    PMID: 37074225
  18. 18

    Hypoparathyroidism with a TBX1 variant: reconsidering genetic etiologies in the absence of 22q11.2 deletions.

    Alsayed Hasan M, Sultan R

    JCEM case reports 2026; (4(10)):luag258 doi:10.1210/jcemcr/luag258.

    PMID: 42750915
  19. 19

    Infantile 22q11.2 deletion syndrome with secondary monogenic variants following inconclusive whole exome sequencing: a case report.

    Abadi A, Ghanem UI, Badran B, et al.

    Frontiers in pediatrics 2026; (14()):1964147 doi:10.3389/fped.2026.1964147.

    PMID: 42845796
  20. 20

    [Clinical and genetic characteristics of primary hypoparathyroidism in children].

    Song FY, Du M, Dong Q, et al.

    Zhonghua er ke za zhi = Chinese journal of pediatrics 2020; (58(11)):917-922 doi:10.3760/cma.j.cn112140-20200317-00258.

    PMID: 33120464
  21. 21

    Clinical and mutational spectrum of hypoparathyroidism, deafness and renal dysplasia syndrome.

    Belge H, Dahan K, Cambier JF, et al.

    Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association 2017; (32(5)):830-837 doi:10.1093/ndt/gfw271.

    PMID: 27387476
  22. 22

    Autoimmune Polyendocrinopathy-Candidiasis-Ectodermal Dystrophy.

    Ferré EMN, Schmitt MM, Lionakis MS

    Frontiers in pediatrics 2021; (9()):723532 doi:10.3389/fped.2021.723532.

    PMID: 34790633
  23. 23

    Clinical, Genetic and Immunological Characteristics of Paediatric Autoimmune Polyglandular Syndrome Type 1 Patients in Slovenia.

    Bratanic N, Kisand K, Avbelj Stefanija M, et al.

    Zdravstveno varstvo 2015; (54(2)):112-8 doi:10.1515/sjph-2015-0017.

    PMID: 27646917
  24. 24

    Novel Glial Cells Missing-2 (GCM2) variants in parathyroid disorders.

    Canaff L, Guarnieri V, Kim Y, et al.

    European journal of endocrinology 2022; (186(3)):351-366 doi:10.1530/EJE-21-0433.

    PMID: 35038313
  25. 25

    Rare cause of persistent hypocalcaemia in infancy due to PTH gene mutation.

    Khadse S, Takalikar VS, Ghildiyal R, Shah N

    BMJ case reports 2023; (16(9)) doi:10.1136/bcr-2023-256358.

    PMID: 37699739
  26. 26

    [Observation of an index case of an autosomal dominant familial hypoparathyroidism revealed by recurrent hypocalcemia: a case report].

    Mouandilmadji DM, Sene M, Dieme A, et al.

    The Pan African medical journal 2026; (53()):40 doi:10.11604/pamj.2026.53.40.50439.

    PMID: 42153160
  27. 27

    Basic principles of genetics and genetic counselling.

    Beelen NJ, Vohra J, Verdonschot JAJ

    Indian pacing and electrophysiology journal 2025; (25(3)):177-184 doi:10.1016/j.ipej.2025.05.002.

    PMID: 40441529
  28. 28

    Epidemiology and Health-Related Quality of Life in Hypoparathyroidism in Norway.

    Astor MC, Løvås K, Debowska A, et al.

    The Journal of clinical endocrinology and metabolism 2016; (101(8)):3045-53 doi:10.1210/jc.2016-1477.

    PMID: 27186861

This page is for informational purposes only and does not constitute medical advice. An endocrinologist and genetics professional can help decide whether testing is appropriate for your situation.